Bis-anthracenyl isoxazolyl amides have enhanced anticancer activity.
about
AIMing towards improved antitumor efficacy.Ethyl 3-(9-chloro-10-oxo-9,10-di-hydro-anthracen-9-yl)-5-methyl-isoxazole-4-carboxyl-ateEthyl 3-(10-bromo-anthracen-9-yl)-5-methyl-1,2-oxazole-4-carboxyl-ateSynthesis and evaluation of new bis-1,3,4,2-triazaphospholinoalkane derivatives as in vitro α-amylase and lipase inhibitors.Improved synthesis of 3-aryl isoxazoles containing fused aromatic rings.
P2860
Bis-anthracenyl isoxazolyl amides have enhanced anticancer activity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bis-anthracenyl isoxazolyl amides have enhanced anticancer activity.
@en
Bis-anthracenyl isoxazolyl amides have enhanced anticancer activity.
@nl
type
label
Bis-anthracenyl isoxazolyl amides have enhanced anticancer activity.
@en
Bis-anthracenyl isoxazolyl amides have enhanced anticancer activity.
@nl
prefLabel
Bis-anthracenyl isoxazolyl amides have enhanced anticancer activity.
@en
Bis-anthracenyl isoxazolyl amides have enhanced anticancer activity.
@nl
P2093
P2860
P1476
Bis-anthracenyl isoxazolyl amides have enhanced anticancer activity.
@en
P2093
Howard Beall
Kevin C Rider
Mariusz P Gajewski
Mark Schnieder
Michael D Mosher
Nicholas R Natale
Sarah M Stranahan
P2860
P304
P356
10.1016/J.BMCL.2009.06.019
P407
P577
2009-06-13T00:00:00Z